Giovanni A Tommaselli1, Valerio Napolitano2, Costantino Di Carlo3, Carmen Formisano3, Annamaria Fabozzi3, Carmine Nappi4. 1. Department of Obstetrics, Gynecology, and Urology, University of Naples "Federico II", Via S. Pansini, 5, 80131 Naples, Italy. Electronic address: gtommaselli@yahoo.it. 2. Urogynecology Service, Department of Obstetrics and Gynaecology, San Giovanni Evangelista Hospital, Via Parrozzani, 5, 00019 Tivoli (RM), Italy. 3. Department of Obstetrics, Gynecology, and Urology, University of Naples "Federico II", Via S. Pansini, 5, 80131 Naples, Italy. 4. Department of Obstetrics, Gynecology, and Urology, University of Naples "Federico II", Via S. Pansini, 5, 80131 Naples, Italy; Department of Public Health, Univesity of Naples "Federico II", Via S. Pansini, 5, 80131 Naples, Italy.
Abstract
OBJECTIVE: To investigate if TVT-Abbrevo has similar outcomes in normal weight and overweight patients. STUDY DESIGN: Retrospective evaluation of 205 (105 normal weight women and 100 overweight women with BMI ≥ 25 kg/m(2)) undergone TVT-Abbrevo positioning with 12 month follow-up. Primary outcomes were objective cure rate (defined as no leakage during CST) and subjective cure rate ("very much improved"/"much improved" at PGI-I), secondary outcomes were intra-operative and post-operative complications. RESULTS: Objective cure rates in the normal and overweight groups were 96.2% and 94%, respectively (p=.47). Subjective cure rates in the normal and overweight groups were 90.5% and 88%, respectively (p=.57). ICIQ-SF, I-QoL and PGI-S scores significantly improved in both groups with no differences between the two groups. No serious intra- or post-operative complications were observed. No differences were observed in pain VAS scores and number of analgesic vials administered. CONCLUSIONS: TVT-Abbrevo seems to have similar efficacy and safety in normal weight and overweight women. More studies are needed to assess the efficacy of this device in frankly obese women and long-term outcomes.
OBJECTIVE: To investigate if TVT-Abbrevo has similar outcomes in normal weight and overweight patients. STUDY DESIGN: Retrospective evaluation of 205 (105 normal weight women and 100 overweight women with BMI ≥ 25 kg/m(2)) undergone TVT-Abbrevo positioning with 12 month follow-up. Primary outcomes were objective cure rate (defined as no leakage during CST) and subjective cure rate ("very much improved"/"much improved" at PGI-I), secondary outcomes were intra-operative and post-operative complications. RESULTS: Objective cure rates in the normal and overweight groups were 96.2% and 94%, respectively (p=.47). Subjective cure rates in the normal and overweight groups were 90.5% and 88%, respectively (p=.57). ICIQ-SF, I-QoL and PGI-S scores significantly improved in both groups with no differences between the two groups. No serious intra- or post-operative complications were observed. No differences were observed in pain VAS scores and number of analgesic vials administered. CONCLUSIONS:TVT-Abbrevo seems to have similar efficacy and safety in normal weight and overweight women. More studies are needed to assess the efficacy of this device in frankly obesewomen and long-term outcomes.
Authors: Wojciech Majkusiak; Andrzej Pomian; Edyta Horosz; Aneta Zwierzchowska; Paweł Tomasik; Wojciech Lisik; Ewa Barcz Journal: PLoS One Date: 2018-11-12 Impact factor: 3.240